Altrinsic Global Advisors’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-270,000
| Closed | -$1.9M | – | 77 |
|
2021
Q4 | $1.9M | Hold |
270,000
| – | – | 0.06% | 58 |
|
2021
Q3 | $3.08M | Buy |
270,000
+30,000
| +13% | +$342K | 0.09% | 54 |
|
2021
Q2 | $3.84M | Hold |
240,000
| – | – | 0.12% | 52 |
|
2021
Q1 | $4.29M | Hold |
240,000
| – | – | 0.14% | 53 |
|
2020
Q4 | $3.24M | Buy |
240,000
+30,000
| +14% | +$405K | 0.11% | 50 |
|
2020
Q3 | $2.47M | Buy |
210,000
+60,000
| +40% | +$706K | 0.1% | 52 |
|
2020
Q2 | $2.21M | Buy |
150,000
+30,000
| +25% | +$443K | 0.1% | 53 |
|
2020
Q1 | $1.62M | Hold |
120,000
| – | – | 0.09% | 54 |
|
2019
Q4 | $2.9M | Hold |
120,000
| – | – | 0.12% | 47 |
|
2019
Q3 | $2.31M | Buy |
120,000
+10,000
| +9% | +$192K | 0.1% | 51 |
|
2019
Q2 | $3.25M | Buy |
110,000
+15,000
| +16% | +$443K | 0.15% | 47 |
|
2019
Q1 | $4.51M | Hold |
95,000
| – | – | 0.21% | 45 |
|
2018
Q4 | $3.43M | Buy |
95,000
+65,000
| +217% | +$2.35M | 0.16% | 50 |
|
2018
Q3 | $1.85M | Buy |
+30,000
| New | +$1.85M | 0.08% | 63 |
|